3/6
01:52 pm
bvs
Bioventus (BVS) had its price target raised by Barrington Research from $13.00 to $14.00. They now have an "outperform" rating on the stock.
Low
Report
Bioventus (BVS) had its price target raised by Barrington Research from $13.00 to $14.00. They now have an "outperform" rating on the stock.
3/6
01:21 pm
bvs
Bioventus (BVS) had its price target raised by Craig Hallum from $15.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Bioventus (BVS) had its price target raised by Craig Hallum from $15.00 to $16.00. They now have a "buy" rating on the stock.
3/5
06:54 pm
bvs
Bioventus Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Bioventus Q4 Earnings Call Highlights [Yahoo! Finance]
3/5
10:32 am
bvs
Bioventus outlines $600M–$610M 2026 sales target with accelerated investment in PNS, PRP, and ultrasonics [Seeking Alpha]
Low
Report
Bioventus outlines $600M–$610M 2026 sales target with accelerated investment in PNS, PRP, and ultrasonics [Seeking Alpha]
3/5
10:26 am
bvs
Bioventus Inc. (BVS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Bioventus Inc. (BVS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/5
10:03 am
bvs
Bioventus (BVS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bioventus (BVS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/5
07:56 am
bvs
Bioventus (BVS) was upgraded by Cantor Fitzgerald to "strong-buy".
Low
Report
Bioventus (BVS) was upgraded by Cantor Fitzgerald to "strong-buy".
3/5
07:43 am
bvs
Bioventus: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Bioventus: Q4 Earnings Snapshot [Yahoo! Finance]
3/5
07:18 am
bvs
Bioventus Non-GAAP EPS of $0.24 beats by $0.02, revenue of $157.9M beats by $2.95M [Seeking Alpha]
Low
Report
Bioventus Non-GAAP EPS of $0.24 beats by $0.02, revenue of $157.9M beats by $2.95M [Seeking Alpha]
3/5
07:15 am
bvs
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/5
07:00 am
bvs
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
2/24
04:48 pm
bvs
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 [Yahoo! Finance]
Low
Report
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 [Yahoo! Finance]
2/24
04:15 pm
bvs
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
Low
Report
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
2/10
07:01 am
bvs
Bioventus (NASDAQ:BVS) was upgraded by analysts at Barrington Research to a "strong-buy" rating.
Medium
Report
Bioventus (NASDAQ:BVS) was upgraded by analysts at Barrington Research to a "strong-buy" rating.
2/9
08:04 am
bvs
Bioventus (NYSE:BVS) is now covered by analysts at Barrington Research. They set an "outperform" rating and a $13.00 price target on the stock.
Medium
Report
Bioventus (NYSE:BVS) is now covered by analysts at Barrington Research. They set an "outperform" rating and a $13.00 price target on the stock.
1/15
08:21 pm
bvs
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference [Yahoo! Finance]
Low
Report
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference [Yahoo! Finance]
1/6
08:17 am
bvs
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/6
07:30 am
bvs
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference